Amrize (NYSE:AMRZ) Now Covered by Analysts at Barclays

Stock analysts at Barclays assumed coverage on shares of Amrize (NYSE:AMRZGet Free Report) in a research report issued on Tuesday,Benzinga reports. The brokerage set an “equal weight” rating on the stock.

Other research analysts also recently issued research reports about the stock. Royal Bank Of Canada dropped their price objective on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. JPMorgan Chase & Co. boosted their price target on Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research note on Tuesday, August 26th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amrize in a report on Saturday, September 27th. Oppenheimer began coverage on Amrize in a research report on Tuesday, September 9th. They set an “outperform” rating and a $62.00 price objective on the stock. Finally, Zacks Research lowered Amrize from a “hold” rating to a “strong sell” rating in a research note on Wednesday, August 27th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $58.67.

View Our Latest Research Report on AMRZ

Amrize Stock Down 0.7%

Shares of NYSE AMRZ opened at $48.38 on Tuesday. Amrize has a 12 month low of $44.12 and a 12 month high of $56.29. The stock has a 50 day simple moving average of $51.00. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.03 by ($0.25).

Insider Transactions at Amrize

In other Amrize news, insider Jaime Hill purchased 4,000 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was acquired at an average cost of $51.99 per share, with a total value of $207,960.00. Following the completion of the purchase, the insider directly owned 13,601 shares in the company, valued at approximately $707,115.99. This represents a 41.66% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jan Philipp Jenisch acquired 50,000 shares of the business’s stock in a transaction that occurred on Monday, August 11th. The stock was acquired at an average price of $47.50 per share, for a total transaction of $2,375,000.00. Following the completion of the acquisition, the chief executive officer directly owned 450,000 shares of the company’s stock, valued at $21,375,000. This trade represents a 12.50% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 1,124,000 shares of company stock valued at $53,225,260.

Institutional Investors Weigh In On Amrize

A number of institutional investors have recently made changes to their positions in the stock. Virtus Family Office LLC acquired a new position in Amrize in the second quarter valued at about $253,000. Teacher Retirement System of Texas bought a new stake in shares of Amrize in the 2nd quarter valued at about $11,149,000. Bessemer Group Inc. acquired a new stake in shares of Amrize in the 2nd quarter valued at approximately $16,489,000. Wesleyan Assurance Society bought a new position in Amrize during the 2nd quarter worth approximately $2,343,000. Finally, FNY Investment Advisers LLC acquired a new position in Amrize during the second quarter valued at approximately $372,000.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.